AI Small-Molecule Design & Optimization | AlanMolecularAI™

AlanMolecularAI™ is an AI-assisted platform for small-molecule generation, analog design, and molecular optimization. Starting from an existing molecule or selected molecular fragment, the platform explores new chemical structures according to user-defined targets, properties, and optimization objectives.

AlanMolecularAI™ combines molecular generation with property prediction, ADMET-related evaluation, structure–activity analysis, and candidate prioritization to help researchers explore chemical space before compound synthesis and experimental validation.

The goal is to transform a molecular starting point into a focused set of computationally prioritized analogs for downstream medicinal chemistry, docking, synthesis, and biological testing.

AlanMolecularAI™ integrates molecular optimization with predictive models for candidate generation, evaluation, and prioritization.

What Can AlanMolecularAI™ Do?

Research Need	AlanMolecularAI™ Approach	Output
Optimize an Existing Molecule	Explore structural analogs around a starting compound	Prioritized molecular analogs
Preserve a Core Scaffold	Select variable and constant molecular fragments	Analogs retaining selected structural features
Optimize a Defined Property	Generate candidates according to a selected target and optimization objective	Property-directed molecular candidates
Balance Multiple Properties	Compare candidates across molecular and predicted property metrics	Multi-parameter candidate ranking
Explore Structure–Activity Relationships	Compare structural changes with predicted molecular properties	Analog series for SAR exploration
Prepare Candidates for Further Evaluation	Prioritize selected molecules for docking or experimental testing	Shortlisted compounds for downstream research

AlanMolecularAI™ Workflow

1. Input or Draw a Starting Molecule

A project begins with an existing molecular structure. Users can draw a molecule directly in the platform or provide a molecular structure using SMILES.

The starting structure provides the chemical framework from which new analogs and optimization strategies can be explored.

AlanMolecularAI molecule input interface for drawing a chemical structure or entering SMILES — AlanMolecularAI™ molecule input interface for structure drawing and SMILES-based input.

2. Select the Molecular Region to Optimize

AlanMolecularAI™ can identify molecular fragments within the starting compound and allow the user to define which structural region should be varied.

A constant fragment can be retained while a variable fragment is selected for analog generation. This allows chemical exploration to remain focused around a scaffold or structural feature considered important to the project.

Example fragment-selection interface for defining variable and retained regions of a starting molecule.

3. Define the Target and Optimization Objective

Users can configure the molecular generation task according to the biological target, optimization objective, desired value range, and number of analogs.

Depending on the available models and project configuration, optimization objectives can include target-related activity, toxicity, ADMET-related properties, and other molecular characteristics.

This enables candidate generation to be directed toward a defined research objective rather than simply producing random structural variations.

AlanMolecularAI™ generation settings allow users to define a target, optimization objective, value range, and number of molecular analogs.

4. Generate and Evaluate Molecular Analogs

AlanMolecularAI™ generates structural analogs that preserve the selected molecular framework while introducing controlled modifications to the variable region.

Generated candidates can be compared using molecular descriptors and predictive properties such as:

Molecular weight (MolWt)
Topological polar surface area (TPSA)
Lipophilicity-related descriptors such as SLogP
Synthetic accessibility (SA)
Quantitative estimate of drug-likeness (QED)
Target- or project-specific predicted properties

This allows researchers to compare both chemical structure and predicted molecular profile when selecting candidates for further investigation.

Example AlanMolecularAI™ output showing generated analogs and selected molecular-property descriptors.

How AlanMolecularAI™ Evaluates Candidates

Small-molecule optimization is rarely a single-property problem. Improving one characteristic can negatively affect another, making multi-parameter evaluation important during lead optimization.

AlanMolecularAI™ is designed to compare generated molecules across several computational dimensions rather than relying on one isolated prediction.

Evaluation Area	Role in Molecular Optimization
Structural Similarity & Scaffold Retention	Controls how closely generated analogs remain related to the molecular starting point
Target-Related Prediction	Supports prioritization of compounds according to the selected biological target
ADMET-Related Properties	Evaluates selected absorption, distribution, metabolism, excretion, or toxicity-related endpoints
Physicochemical Properties	Compares descriptors such as molecular weight, TPSA, and lipophilicity
Drug-Likeness	Provides additional information for comparing candidate molecular profiles
Synthetic Accessibility	Supports assessment of whether proposed structures may be practical candidates for chemical synthesis

Technology Behind AlanMolecularAI™

AlanMolecularAI™ uses a proprietary molecular optimization framework built from target–compound information and molecular property models.

The current platform architecture incorporates a molecular optimization model trained using data covering 50,000+ biological targets and associated active compounds, together with focused datasets and predictive models used during candidate evaluation.

Component	Role in AlanMolecularAI™
Molecular Optimization Model	Generates and optimizes molecular structures according to project objectives
Focused Target Data	Provides target-specific information for molecular design and optimization
ADMET Models	Evaluate selected pharmacokinetic and safety-related properties
SAR Analysis	Supports interpretation of relationships between structural changes and predicted activity
Property Prediction	Provides molecular descriptors and computational candidate profiles
Docking Integration	Allows selected candidates to proceed to structural target-interaction analysis

What Does AlanMolecularAI™ Deliver?

Deliverable	Description
Generated Molecular Analogs	New chemical structures derived from the selected molecular starting point
SMILES & 2D Structures	Machine-readable molecular representations and visual chemical structures
Molecular Descriptors	Properties such as molecular weight, TPSA, SLogP, SA, and QED
Predicted Properties	Target- and project-specific computational predictions where available
Candidate Comparison	Side-by-side evaluation of generated molecular analogs
Prioritized Candidates	A focused set of compounds for downstream docking, synthesis, or experimental testing

Applications of AlanMolecularAI™

Hit-to-Lead Optimization

Start from an existing hit or active molecular scaffold and explore structural analogs that may provide improved predicted properties while retaining important chemical features.

Lead Optimization

Explore structural modifications around an existing lead while balancing target-related predictions, physicochemical properties, ADMET-related endpoints, and synthetic accessibility.

Analog Generation

Generate focused analog series around a selected scaffold or molecular fragment for medicinal chemistry and structure–activity relationship studies.

ADMET-Oriented Molecular Optimization

Use predictive models to identify molecular modifications that may improve selected ADMET-related properties before committing compounds to synthesis and experimental testing.

Structure–Activity Relationship Exploration

Compare changes in molecular structure with predicted activity and molecular-property profiles to support SAR hypothesis generation and compound prioritization.

From Molecular Generation to Docking

Selected AlanMolecularAI™ candidates can proceed directly to AlanDockAI™ for molecular docking and structural interaction analysis.

Starting Molecule → Fragment Selection → AI Optimization → Candidate Generation → Property Evaluation → AlanDockAI™ → Experimental Validation

This connection allows molecular generation and structural target evaluation to operate as complementary stages of the same computational drug-discovery workflow.

Understanding AlanMolecularAI™ Predictions

AlanMolecularAI™ is a computational molecular design and candidate-prioritization platform.

Predicted activity, ADMET properties, molecular descriptors, docking results, and candidate rankings are computational estimates and should not be interpreted as experimentally measured pharmacological or biological properties.

Compound synthesis and experimental validation remain necessary to confirm molecular activity, selectivity, ADMET behavior, and biological performance.

Related Alan Scientific AI Platforms

AlanMolecularAI™ is part of Alan Scientific's integrated suite of AI-assisted molecular and peptide design technologies.

AlanPepAI™
AI-assisted linear peptide design, sequence optimization, structural evaluation, and candidate prioritization.

AlanDockAI™
Automated small-molecule docking and molecular interaction analysis.

HighFoldAI™
AI-assisted cyclic peptide design, structural prediction, and candidate evaluation.

Start an AlanMolecularAI™ Project

To begin a molecular generation or optimization project, provide a starting molecular structure, target information, optimization objective, and relevant project constraints.

AlanMolecularAI™ can then generate and evaluate structural analogs for downstream prioritization, docking, synthesis, and experimental validation.

Each molecular generation or optimization project currently requires 50 credits.

Start AlanMolecularAI™

I have read and agreed to the 《Privacy Policy》

START